• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[原发性乳腺癌患者术前血清CA153、CEA及TPS水平的临床及预后意义]

[Clinical and prognostic significance of preoperative serum CA153, CEA and TPS levels in patients with primary breast cancer].

作者信息

Chen Yan, Zheng Yu-hong, Lin Ying-ying, Hu Min-hua, Chen Yan-song

机构信息

Clinical Laboratory Department, Fujian Medical University Teaching Hospital, Fuzhou, Fujian, China.

出版信息

Zhonghua Zhong Liu Za Zhi. 2011 Nov;33(11):842-6.

PMID:22335950
Abstract

OBJECTIVE

To investigate the clinical and prognostic values of preoperative serum CA153, CEA and TPS levels in patients with primary breast cancer.

METHODS

A total of 386 hospitalized patients with stage I ∼ IV breast cancer from Nov 1998 to Feb 2009 were followed up, and their clinicopathological data were analyzed retrospectively to determine the factors affecting their prognosis.

RESULTS

First, preoperative serum CA153 expression level was significantly associated with the age of onset and tumor size (P < 0.05), the expression of serum CEA was correlated with tumor size (P < 0.05), and the expression of serum tissue polypeptide specific antigen (TPS) was correlated with tumor size and lymph node metastases (P < 0.05). Second, the overall survival was significantly shorter among patients with elevated serum CA153, CEA or TPS, respectively (P < 0.05 for overall). Finally, multivariate Cox regression analysis indicated that estrogen receptor status (ER) and elevated preoperative values of CA 153 are independent prognostic factors for overall survival (P < 0.05), and CA 153 is a risk factor but estrogen receptor status is a protective factor for overall survival.

CONCLUSIONS

Higher preoperative expression of serum CA153, CEA or TPS is closely correlated with clinicopathological characteristics and overall survival. The prognosis is poorer in primary breast cancer patients with higher CA15-3 expression level, and pre-treatment CA153 expression level can be used as an independent prognostic parameter in patients with primarily breast cancer.

摘要

目的

探讨术前血清CA153、CEA及TPS水平在原发性乳腺癌患者中的临床及预后价值。

方法

对1998年11月至2009年2月期间住院的386例Ⅰ~Ⅳ期乳腺癌患者进行随访,并对其临床病理资料进行回顾性分析,以确定影响其预后的因素。

结果

首先,术前血清CA153表达水平与发病年龄及肿瘤大小显著相关(P<0.05),血清CEA表达与肿瘤大小相关(P<0.05),血清组织多肽特异性抗原(TPS)表达与肿瘤大小及淋巴结转移相关(P<0.05)。其次,血清CA153、CEA或TPS升高的患者总体生存期分别显著缩短(总体P<0.05)。最后,多因素Cox回归分析表明,雌激素受体状态(ER)及术前CA153值升高是总体生存的独立预后因素(P<0.05),CA153是总体生存的危险因素,而雌激素受体状态是保护因素。

结论

术前血清CA153、CEA或TPS的高表达与临床病理特征及总体生存密切相关。CA15-3表达水平较高的原发性乳腺癌患者预后较差,术前CA153表达水平可作为原发性乳腺癌患者的独立预后参数。

相似文献

1
[Clinical and prognostic significance of preoperative serum CA153, CEA and TPS levels in patients with primary breast cancer].[原发性乳腺癌患者术前血清CA153、CEA及TPS水平的临床及预后意义]
Zhonghua Zhong Liu Za Zhi. 2011 Nov;33(11):842-6.
2
[Diagnostic value of combined detection of TPS, CA153 and CEA in breast cancer].[TPS、CA153和CEA联合检测在乳腺癌中的诊断价值]
Di Yi Jun Yi Da Xue Xue Bao. 2005 Oct;25(10):1293-4, 1298.
3
Prognostic significance of serum Her2/neu, BCL2, CA15-3 and CEA in breast cancer patients: a short follow-up.乳腺癌患者血清 Her2/neu、BCL2、CA15-3 和 CEA 的预后意义:短期随访。
Cancer Biomark. 2010;6(2):63-72. doi: 10.3233/CBM-2009-0119.
4
Comparison of TPS with CEA and CA 15.3 in follow-up of Chinese breast cancer patients.中国乳腺癌患者随访中 TPS 与癌胚抗原(CEA)及糖类抗原 15.3(CA 15.3)的比较
Anticancer Res. 2002 May-Jun;22(3):1865-8.
5
Relationship between tumor markers CEA and CA 15-3, TNM staging, estrogen receptor rate and MIB-1 index in patients with pT1-2 breast cancer.pT1-2期乳腺癌患者肿瘤标志物癌胚抗原(CEA)和糖类抗原15-3(CA 15-3)、TNM分期、雌激素受体率及MIB-1指数之间的关系
Anticancer Res. 2004 Sep-Oct;24(5B):3221-4.
6
Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer.血清肿瘤标志物癌胚抗原(CEA)和糖类抗原15-3(CA15-3)水平升高是乳腺癌不同分子亚型的预后参数。
PLoS One. 2015 Jul 24;10(7):e0133830. doi: 10.1371/journal.pone.0133830. eCollection 2015.
7
TPS and CA 15.3 serum values as a guide for treating and monitoring breast cancer patients.TPS和CA 15.3血清值作为治疗和监测乳腺癌患者的指导指标。
Anticancer Res. 1996 Mar-Apr;16(2):875-81.
8
[Clinical study of serum tissue polypeptide-specific antigen in breast cancer].[血清组织多肽特异性抗原在乳腺癌中的临床研究]
Di Yi Jun Yi Da Xue Xue Bao. 2003 Aug;23(8):823-5.
9
Prospective evaluation of CEA and CA 15.3 in patients with locoregional breast cancer.局部区域性乳腺癌患者癌胚抗原(CEA)和糖类抗原15.3(CA 15.3)的前瞻性评估
Anticancer Res. 2003 Mar-Apr;23(2A):1035-41.
10
Serum tissue polypeptide specific antigen (TPS) in breast cancer patients: comparison with CA 15.3 and CEA.乳腺癌患者血清组织多肽特异性抗原(TPS):与CA 15.3和癌胚抗原的比较
Anticancer Res. 1995 Jul-Aug;15(4):1609-11.

引用本文的文献

1
Serum CA125 is a predictive marker for breast cancer outcomes and correlates with molecular subtypes.血清CA125是乳腺癌预后的预测标志物,且与分子亚型相关。
Oncotarget. 2017 Jul 12;8(38):63963-63970. doi: 10.18632/oncotarget.19246. eCollection 2017 Sep 8.
2
Nomograms for Predicting the Prognostic Value of Pre-Therapeutic CA15-3 and CEA Serum Levels in TNBC Patients.预测三阴性乳腺癌患者治疗前CA15-3和CEA血清水平预后价值的列线图
PLoS One. 2016 Aug 25;11(8):e0161902. doi: 10.1371/journal.pone.0161902. eCollection 2016.